Central nervous system lymphoma: characteristic findings on traditional and advanced imaging (Q33628451)

28 July 2017

1 reference

title

Central nervous system lymphoma: characteristic findings on traditional and advanced imaging (English)

1 reference

central nervous system lymphoma

28 July 2017

1 reference

0 references

1

1 reference

28 July 2017

A Espeland

2

1 reference

PubMed ID

20616176

28 July 2017

E-M Larsson

series ordinal

3

1 reference

28 July 2017

8 July 2010

1 reference

American Journal of Neuroradiology

28 July 2017

1 reference

28 July 2017

32

1 reference

28 July 2017

6

1 reference

28 July 2017

984-992

1 reference

Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities

28 July 2017

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

CNS prophylaxis in lymphoma: who to target and what therapy to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Secondary central nervous system lymphoma: risk factors and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Diagnostic delay in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Therapeutic challenges in primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

MRI features of primary central nervous system lymphomas at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Treatment of CNS dissemination in systemic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Clinical features and diagnosis of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary central nervous system lymphoma: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Lymphomatosis cerebri presenting as rapidly progressive dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary lymphoma of the central nervous system: typical and atypical CT and MR imaging appearances.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Fifty years of the congress of neurological surgeons: foundations, objectives, and legacies

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

MRI characteristics of acute and subacute brainstem and thalamic infarctions: value of T2- and diffusion-weighted sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Technical aspects of perfusion-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Brain perfusion CT: principles, technique and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Potential role of CT perfusion parameters in the identification of solitary intra-axial brain tumor grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Neuroimaging of HIV and AIDS related illnesses: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

High 123I-IMP retention on SPECT image in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

Advances in evaluation of primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

The potential of PET/MR for brain imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2171

21 January 2018

Identifiers

DOI

10.3174/AJNR.A2171

1 reference

28 July 2017

1 reference

PubMed ID

20616176